Market Overview

Mizuho Securities Initiates Coverage on AcelRx Pharmaceuticals, Inc. at Buy, Announces $13.00 PT

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ACRX

DateFirmActionFromTo
Aug 2014JefferiesMaintainsBuy
Jul 2014Piper JaffrayDowngradesOverweightNeutral
Jul 2014Canaccord GenuityDowngradesBuyHold

View More Analyst Ratings for ACRX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (ACRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters